Format

Send to

Choose Destination
See comment in PubMed Commons below
Methods. 2008 Dec;46(4):241-7. doi: 10.1016/j.ymeth.2008.09.008. Epub 2008 Oct 10.

Mouse models of oxidative phosphorylation dysfunction and disease.

Author information

1
Department of Neurology, University of Miami, USA.

Abstract

Oxidative phosphorylation (OXPHOS) deficiency results in a number of human diseases, affecting at least one in 5000 of the general population. Altering the function of genes by mutations are central to our understanding their function. Prior to the development of gene targeting, this approach was limited to rare spontaneous mutations that resulted in a phenotype. Since its discovery, targeted mutagenesis of the mouse germline has proved to be a powerful approach to understand the in vivo function of genes. Gene targeting has yielded remarkable understanding of the role of several gene products in the OXPHOS system. We provide a "tool box" of mouse models with OXPHOS defects that could be used to answer diverse scientific questions.

PMID:
18848991
PMCID:
PMC2652743
DOI:
10.1016/j.ymeth.2008.09.008
[Indexed for MEDLINE]
Free PMC Article

Publication types, MeSH terms, Substances, Grant support

Publication types

MeSH terms

Substances

Grant support

PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center